Radiation boost powers immune attack on cancer before surgery
NCT ID NCT07371234
Summary
This study is testing a new two-part treatment given before surgery for advanced head and neck cancer. Doctors combine a low dose of radiation with an immunotherapy drug (an anti-PD-1 inhibitor) to try to shrink tumors and improve long-term results. The goal is to see if this combination helps patients live longer and reduces the chance of the cancer coming back after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Fifth Affiliated Hospital,Sun Yat-sen University
RECRUITINGGuangdong, China
Conditions
Explore the condition pages connected to this study.